JP5828594B2 - 溶融ピロロカルバゾール誘導体を精製するための方法 - Google Patents

溶融ピロロカルバゾール誘導体を精製するための方法 Download PDF

Info

Publication number
JP5828594B2
JP5828594B2 JP2013511294A JP2013511294A JP5828594B2 JP 5828594 B2 JP5828594 B2 JP 5828594B2 JP 2013511294 A JP2013511294 A JP 2013511294A JP 2013511294 A JP2013511294 A JP 2013511294A JP 5828594 B2 JP5828594 B2 JP 5828594B2
Authority
JP
Japan
Prior art keywords
formula
compound
complex
acid
butanol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2013511294A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013526573A5 (cg-RX-API-DMAC7.html
JP2013526573A (ja
Inventor
ピー. アールウェイン、ショーン
ピー. アールウェイン、ショーン
アルノー グランドューリー
アルノー グランドューリー
ピアチェンザ、ギー
ローズ、セバスチャン
Original Assignee
セファロン、インク.
テバ サンテ
テバ サンテ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by セファロン、インク., テバ サンテ, テバ サンテ filed Critical セファロン、インク.
Publication of JP2013526573A publication Critical patent/JP2013526573A/ja
Publication of JP2013526573A5 publication Critical patent/JP2013526573A5/ja
Application granted granted Critical
Publication of JP5828594B2 publication Critical patent/JP5828594B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/80[b, c]- or [b, d]-condensed
    • C07D209/82Carbazoles; Hydrogenated carbazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP2013511294A 2010-05-18 2011-05-17 溶融ピロロカルバゾール誘導体を精製するための方法 Active JP5828594B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US34583110P 2010-05-18 2010-05-18
US61/345,831 2010-05-18
PCT/US2011/036814 WO2011146488A1 (en) 2010-05-18 2011-05-17 Method for purifying a fused pyrrolocarbazole derivative

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015205469A Division JP2016074668A (ja) 2010-05-18 2015-10-19 溶融ピロロカルバゾール誘導体を精製するための方法

Publications (3)

Publication Number Publication Date
JP2013526573A JP2013526573A (ja) 2013-06-24
JP2013526573A5 JP2013526573A5 (cg-RX-API-DMAC7.html) 2014-07-03
JP5828594B2 true JP5828594B2 (ja) 2015-12-09

Family

ID=44168420

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2013511294A Active JP5828594B2 (ja) 2010-05-18 2011-05-17 溶融ピロロカルバゾール誘導体を精製するための方法
JP2015205469A Pending JP2016074668A (ja) 2010-05-18 2015-10-19 溶融ピロロカルバゾール誘導体を精製するための方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2015205469A Pending JP2016074668A (ja) 2010-05-18 2015-10-19 溶融ピロロカルバゾール誘導体を精製するための方法

Country Status (20)

Country Link
US (1) US8884014B2 (cg-RX-API-DMAC7.html)
EP (1) EP2571885B1 (cg-RX-API-DMAC7.html)
JP (2) JP5828594B2 (cg-RX-API-DMAC7.html)
KR (1) KR101815332B1 (cg-RX-API-DMAC7.html)
CN (1) CN102958934B (cg-RX-API-DMAC7.html)
AU (1) AU2011256264B2 (cg-RX-API-DMAC7.html)
BR (1) BR112012029374B1 (cg-RX-API-DMAC7.html)
CA (1) CA2799517C (cg-RX-API-DMAC7.html)
CL (1) CL2012003208A1 (cg-RX-API-DMAC7.html)
EA (1) EA021869B1 (cg-RX-API-DMAC7.html)
ES (1) ES2530015T3 (cg-RX-API-DMAC7.html)
IL (2) IL223016A0 (cg-RX-API-DMAC7.html)
MX (1) MX2012013304A (cg-RX-API-DMAC7.html)
MY (1) MY156830A (cg-RX-API-DMAC7.html)
NZ (1) NZ604135A (cg-RX-API-DMAC7.html)
PH (1) PH12012502250A1 (cg-RX-API-DMAC7.html)
SG (2) SG10201503541WA (cg-RX-API-DMAC7.html)
UA (1) UA108498C2 (cg-RX-API-DMAC7.html)
WO (1) WO2011146488A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201209305B (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2399588T3 (es) 2008-11-19 2013-04-02 Cephalon, Inc. Nuevas formas de un compuesto de indazolo[5,4-A]pirrolo[3,4-C]carbazol

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60103171T2 (de) * 2000-09-29 2004-11-11 Eli Lilly And Co., Indianapolis Verfahren und verbindungen zur behandlung proliferativer erkrankungen
US7169802B2 (en) 2003-12-23 2007-01-30 Cephalon, Inc. Fused pyrrolocarbazoles
JP2006241579A (ja) 2005-03-07 2006-09-14 Nippon Paint Co Ltd 化成処理剤及び表面処理金属
ES2399588T3 (es) * 2008-11-19 2013-04-02 Cephalon, Inc. Nuevas formas de un compuesto de indazolo[5,4-A]pirrolo[3,4-C]carbazol

Also Published As

Publication number Publication date
ES2530015T3 (es) 2015-02-25
AU2011256264B2 (en) 2016-09-15
MX2012013304A (es) 2013-04-03
JP2016074668A (ja) 2016-05-12
US20130123499A1 (en) 2013-05-16
MY156830A (en) 2016-03-31
WO2011146488A1 (en) 2011-11-24
US8884014B2 (en) 2014-11-11
EP2571885B1 (en) 2014-11-12
SG10201503541WA (en) 2015-06-29
EP2571885A1 (en) 2013-03-27
KR20140095116A (ko) 2014-08-01
EA021869B1 (ru) 2015-09-30
BR112012029374A8 (pt) 2017-12-26
IL242221A0 (en) 2015-11-30
CL2012003208A1 (es) 2013-05-17
KR101815332B1 (ko) 2018-01-04
AU2011256264A1 (en) 2013-01-10
CN102958934A (zh) 2013-03-06
IL223016A0 (en) 2013-02-03
IL242221B (en) 2018-06-28
BR112012029374B1 (pt) 2021-05-25
CN102958934B (zh) 2015-06-17
CA2799517A1 (en) 2011-11-24
PH12012502250A1 (en) 2013-02-04
HK1182100A1 (en) 2013-11-22
CA2799517C (en) 2019-01-22
BR112012029374A2 (pt) 2016-07-26
NZ604135A (en) 2015-02-27
JP2013526573A (ja) 2013-06-24
EA201291269A1 (ru) 2013-05-30
UA108498C2 (en) 2015-05-12
SG185645A1 (en) 2012-12-28
ZA201209305B (en) 2014-02-26

Similar Documents

Publication Publication Date Title
JP2005504086A5 (cg-RX-API-DMAC7.html)
JP5828594B2 (ja) 溶融ピロロカルバゾール誘導体を精製するための方法
JP6340471B2 (ja) アピキサバンの製造方法
WO2015014984A1 (en) A process for preparing rifaximin k
CN111499640A (zh) 哌嗪并三唑类衍生物的手性拆分方法
TWI577643B (zh) 單離純化含三丙酮胺反應混合物時所形成的廢水流之處理方法
SI21850A (sl) Soli olanzapina in njihova pretvorba v prosto bazo olanzapina
CN107814757B (zh) 一种合成多取代吡咯衍生物的方法
CN1960982B (zh) 分离1,3-二氧杂环己烷-4,6-二酮化合物的方法
HK1182100B (en) Method for purifying a fused pyrrolocarbazole derivative
JP6462143B2 (ja) 固形結晶形体4−(2−メチル−1h−イミダゾール−1−イル)−2,2−ジフェニルブタンニトリル
JP6571497B2 (ja) ミルタザピンの製造方法
JP7748370B2 (ja) トリアゾリンジオン付加体の製造方法
JP7603598B2 (ja) トリオン化合物の製造方法
JP6008734B2 (ja) オランザピンii型結晶の製造方法
JP6433809B2 (ja) 1−(3−ヒドロキシメチルピリジル−2−)−2−フェニル−4−メチルピペラジンの製造方法
TW202540077A (zh) 具有抗癌活性之mdm2-p53交互作用的異吲哚啉酮抑制劑的中間體的製造方法
US20100179318A1 (en) Process to make lestaurtinib
WO2005085256A1 (en) Isopropanol water solvate of olanzapine
WO2011114336A1 (en) Process for the isolation of ganciclovir intermediate
JPWO2001081300A1 (ja) 2−アセチルチオ−3−フェニルプロピオン酸の晶析法
EA044645B1 (ru) Способ получения апиксабана
JP2017128551A (ja) 1−(3−ヒドロキシメチルピリジル−2−)−2−フェニル−4−メチルピペラジンの製造方法
WO2016021524A1 (ja) 光学活性2-メチルピペラジンの製造方法
EP2109613A2 (en) Polymorphs of eszopiclone malate

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140516

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20140516

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20150324

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20150624

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150713

TRDD Decision of grant or rejection written
A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20150811

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20150818

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20150811

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A712

Effective date: 20150911

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20150916

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20151019

R150 Certificate of patent or registration of utility model

Ref document number: 5828594

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250